EUVIMEDEUVIMED entdecken
Open Access

A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria

Zhijun Chen iD, Wenjun Hu iD, Hui Nie iD, Yifan Zhang iD, Weilin Tang, Zhihe Yu, Jiajun Cao, Xunying Zhu, Xinrong Liu iD, Mingqian Chen iD, Udi Qimron iD, Andrij Pich und 2 weitere

Science Advances · 30.10.2026 · 12 (44)

DOI: 10.1126/sciadv.aeh7105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 30.10.2026. Verfasst von Zhijun Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MO…. Hauptthemen laut MEDLINE: Nanoparticles, Drug Resistance, Multiple, Bacterial, Phage Therapy, Lipids. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, National Natural Science Foundation of China, German Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating crisis of antimicrobial resistance, particularly among Gram-negative bacteria, demands innovative therapeutic strategies. Here, we present a dual-targeting lipid nanoparticle-chimeric phage (AbLCP) system engineered to combat multidrug-resistant (MDR) Gram-negative bacteria. Our design integrates a genetically modified M13 phage displaying anti–lipopolysaccharide (LPS) antibodies with polymyxin B conjugation, which is further encapsulated within anti-LPS antibody–functionalized lipid nanoparticles. This system overcomes the fundamental limitations of conventional phage therapy, enabling efficient cellular internalization, endosomal escape, and potent intracellular bactericidal activity. In murine models of Pseudomonas aeruginosa infection, AbLCP achieved superior bacterial clearance and up to 10 3 -fold reduction in bacterial burden at a 10 3 -fold lower effective dose than free polymyxin B, with 67-fold selective accumulation at infection sites, and attenuated systemic inflammation and preservation of gut microbiota. Mechanistically, AbLCP neutralized LPS to suppress inflammation and induced a lethal bacterial stress response. This work establishes a transformative nanophage platform that merges synthetic biology with nanomedicine, offering a promising strategy against MDR bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesDrug Resistance, Multiple, BacterialPhage TherapyLipidsGram-Negative BacteriaBacteriophage M13Pseudomonas InfectionsAnimalsLipopolysaccharidesMicePseudomonas aeruginosaAnti-Bacterial AgentsPolymyxin BHumansLiposomes

Substanzen

LipopolysaccharidesLipidsAnti-Bacterial AgentsLipid NanoparticlesPolymyxin BLiposomes

Autor:innen und Institutionen

  • Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Huazhong University of Scie…
  • School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Hongshan District, Wuhan 430074, Hubei, China.
  • Department of Clinical Microbiology and Immunology, School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • DWI-Leibniz Institute for Interactive Materials e.V., 52074 Aachen, Germany.
  • Functional and Interactive Polymers, Institute of Technical and Macromolecular Chemistry, RWTH Aachen University, 52074 Aachen, Germany.
  • Aachen Maastricht Institute for Biobased Materials (AMIBM), Maastricht University, Brightlands Chemelot Campus, 6167 RD Geleen, Netherlands.

ORCID-Profile: Zhijun Chen, Wenjun Hu, Hui Nie, Yifan Zhang, Xinrong Liu, Mingqian Chen, Udi Qimron, Huan Peng, Jianfeng Liu

Förderung

  • European Research Council
  • National Natural Science Foundation of China
  • German Science Foundation

Zitieren

APA

Chen, Z., Hu, W., Nie, H., Zhang, Y., Tang, W., Yu, Z., Cao, J., Zhu, X., Liu, X., Chen, M., Qimron, U., Pich, A., Peng, H., & Liu, J. (2026). A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria. Science Advances, 12(44). https://doi.org/10.1126/sciadv.aeh7105

Vancouver

Chen Z, Hu W, Nie H, Zhang Y, Tang W, Yu Z, et al. A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria. Science Advances. 2026;12(44). doi:10.1126/sciadv.aeh7105

BibTeX
@article{Chen2026,
  author = {Chen, Zhijun and Hu, Wenjun and Nie, Hui and Zhang, Yifan and Tang, Weilin and Yu, Zhihe and Cao, Jiajun and Zhu, Xunying and Liu, Xinrong and Chen, Mingqian and Qimron, Udi and Pich, Andrij and Peng, Huan and Liu, Jianfeng},
  title = {A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {44},
  doi = {10.1126/sciadv.aeh7105}
}
Kostenlos starten →